PDGF receptor kinase inhibitors for the treatment of restenosis

被引：75
|
作者：
Levitzki, A [1 ]
机构：
[1] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel
来源：
CARDIOVASCULAR RESEARCH | 2005年 / 65卷 / 03期
关键词：
PDGF; tyrphostins; restenosis; cancer;
D O I：
10.1016/j.cardiores.2004.08.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The clogging of arteries by neointima is a hallmark of atherosclerosis and of restenosis following balloon angioplasty. The realization in the 1980s that PDGF and its receptor play a key role in the onset of neointimal formation led us to develop PDGFR kinase inhibitors as antirestenosis agents. In this review, we describe the development of these inhibitors and their implementation as antirestenosis agents by localized delivery to the site of injury. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：581 / 586
页数：6
相关论文
共 50 条
  • [1] PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases
    Levitzki, A
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) : 229 - 235
  • [2] Synthesis of PDGF receptor tyrosine kinase inhibitors.
    He, W
    Myers, MR
    Spada, AP
    Hanney, BA
    Setzer, N
    Maguire, M
    Mailliet, P
    Gontier, S
    Guegen, JC
    Cans, P
    Orton, E
    Cheve, M
    Kubiak, GG
    Shah, HC
    O'brien, MK
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U128 - U128
  • [3] Pharmacodynamics of PDGF receptor tyrosine kinase inhibitors in irradiated glioblastomas
    Geng, L
    Shinohara, E
    Tan, J
    Hallahan, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S173 - S174
  • [4] The Development of PDGF Receptor Inhibitors for the Treatment of Glioma: A Review
    Badruddoja, Michael A.
    Elquza, Emad
    Welsh, James
    Cooke, Laurence
    Sanan, Abhay
    Stea, Baldassrre
    Mahadavan, Daruka
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2010, 7 (04) : 290 - 299
  • [5] Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis
    Golomb, G
    Fishbein, I
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 24 (01) : 53 - 62
  • [6] The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization
    Dell, Susanne
    Peters, Swaantje
    Muether, Philipp
    Kociok, Norbert
    Joussen, Antonia M.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (05) : 1928 - 1937
  • [7] A NEW SERIES OF PDGF RECEPTOR TYROSINE KINASE INHIBITORS - S-SUBSTITUTED QUINOLINE DERIVATIVES
    MAGUIRE, MP
    SHEETS, KR
    MCVETY, K
    SPADA, AP
    ZILBERSTEIN, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (14) : 2129 - 2137
  • [8] EFFECT OF RECEPTOR KINASE INACTIVATION ON THE RATE OF INTERNALIZATION AND DEGRADATION OF PDGF AND THE PDGF BETA-RECEPTOR
    SORKIN, A
    WESTERMARK, B
    HELDIN, CH
    CLAESSONWELSH, L
    [J]. JOURNAL OF CELL BIOLOGY, 1991, 112 (03): : 469 - 478
  • [9] TNF-α suppresses the PDGF β-receptor kinase
    Molander, C
    Kallin, A
    Izumi, H
    Rönnstrand, L
    Funa, K
    [J]. EXPERIMENTAL CELL RESEARCH, 2000, 258 (01) : 65 - 71
  • [10] Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer
    Laetsch, Theodore W.
    Hong, David S.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (18) : 4974 - 4982
12345